BeyondSpring (BYSI) News Today $2.35 -0.10 (-4.08%) As of 06/30/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BYSI Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period BeyondSpring (NASDAQ:BYSI) Stock Price Down 4.1% - Should You Sell?June 30 at 12:37 AM | marketbeat.comBeyondSpring (NASDAQ:BYSI) Trading Up 30% - Here's WhyJune 9, 2025 | marketbeat.comBeyondSpring reports promising phase 2 NSCLC study resultsJune 5, 2025 | uk.investing.comBeyondSpring Presents Efficacy/Safety Data from a Phase 2 Study of Pembrolizumab plus Plinabulin/Docetaxel in Metastatic NSCLC after Progressing on First-Line Immune Checkpoint Inhibitors at 2025 ASCO Annual MeetingJune 3, 2025 | globenewswire.comBeyondSpring Announces Poster Presentation at 2025 ASCO Annual MeetingMay 29, 2025 | finance.yahoo.comCan BeyondSpring (NASDAQ:BYSI) Afford To Invest In Growth?May 15, 2025 | finance.yahoo.comBeyondSpring (NASDAQ:BYSI) Releases Earnings ResultsMay 14, 2025 | marketbeat.comBeyondSpring, Inc.: BeyondSpring Reports First-Quarter 2025 Financial Results and Provides Corporate UpdateMay 13, 2025 | finanznachrichten.deBeyondSpring Reports First‑Quarter 2025 Financial Results and Provides Corporate UpdateMay 12, 2025 | globenewswire.comBeyondSpring (NASDAQ:BYSI) Stock Price Passes Below 50 Day Moving Average - Time to Sell?April 6, 2025 | marketbeat.comBeyondSpring, Inc.: BeyondSpring Reports 2024 Year-End Financial Results and Highlights Key Clinical & Strategic MilestonesMarch 29, 2025 | finanznachrichten.deBeyondSpring (NASDAQ:BYSI) Stock Price Down 3.8% - What's Next?March 27, 2025 | marketbeat.comBeyondSpring reports FY24 EPS (21c) vs. (34c) last yearMarch 27, 2025 | markets.businessinsider.comBeyondSpring Reports 2024 Year-End Financial Results and Highlights Key Clinical & Strategic MilestonesMarch 27, 2025 | markets.businessinsider.comBeyondSpring Files 2024 Annual Report on Form 10-KMarch 27, 2025 | globenewswire.comBeyondSpring (NASDAQ:BYSI) Shares Up 0.6% - What's Next?February 20, 2025 | marketbeat.comSEED Therapeutics Secures FDA Rare Pediatric and Orphan Drug Designations for ST-01156January 29, 2025 | msn.comBeyondSpring to sell portion of equity interest in SEED for $35.4MEli LillyJanuary 28, 2025 | markets.businessinsider.comBeyondSpring sells SEED Therapeutics shares for $35.4MJanuary 28, 2025 | msn.comSEED Receives FDA Rare Pediatric Disease and Orphan Drug Designations for Lead Oncology Asset RBM39 Degrader and Enters Strategic Transactions with New InvestorsJanuary 28, 2025 | globenewswire.comBeyondSpring Announces $35.4 Million Sale of a Portion of Equity Interest in SEED Therapeutics to Advance Lead Asset Plinabulin to Anti-Cancer Registrational StudiesJanuary 28, 2025 | globenewswire.comBeyondSpring (NASDAQ:BYSI) Shares Down 1.4% - Here's WhyJanuary 24, 2025 | marketbeat.comBeyondSpring (NASDAQ:BYSI) Trading 4.5% Higher - Here's WhyNovember 27, 2024 | marketbeat.comBeyondSpring presents efficacy results from Phase 2 IIT study of plinabulinNovember 12, 2024 | markets.businessinsider.comBeyondSpring Presents Updated Efficacy Results from a Phase 2 IIT Study of Triple IO Combo of Pembrolizumab plus Plinabulin/Docetaxel in Metastatic NSCLC after Progressing on Prior Immune Checkpoint Inhibitors at the 39th SITC Annual MeetingNovember 11, 2024 | globenewswire.comBYSI Sees Quick 5.39% Surge Amid Low Trading VolumeOctober 2, 2024 | gurufocus.comBeyondSpring Presents Efficacy/Safety Results from a Phase 2 Study of Pembrolizumab plus Plinabulin/Docetaxel in Metastatic NSCLC after Progressing on First-Line Immune Checkpoint Inhibitors at ESMO Congress 2024September 16, 2024 | globenewswire.comBeyondSpring Presents Final Data Analysis of DUBLIN-3 Phase 3 Study in 2L/3L EGFR Wild-type NSCLC at ESMO Congress 2024September 16, 2024 | globenewswire.comBeyondSpring (NASDAQ:BYSI) Trading Up 3.3%September 11, 2024 | marketbeat.comBeyondSpring Announces Oral Presentation at the 2024 World Conference on Lung Cancer and Two Poster Presentations During ESMO Congress 2024 Showcasing its Lead Anti-Cancer Asset, PlinabulinSeptember 3, 2024 | globenewswire.comBeyondSpring (NASDAQ:BYSI) Stock Price Down 0.5%August 21, 2024 | marketbeat.comSEED Therapeutics (SEED) Enters into Strategic Research Collaboration with Eisai Co., Ltd. to Discover and Develop Novel Molecular Glue Degraders for Neurodegeneration and Oncology IndicationsAugust 6, 2024 | globenewswire.comBeyondSpring (NASDAQ:BYSI) Trading Up 3.1%July 12, 2024 | marketbeat.comBeyondSpring (NASDAQ:BYSI) Shares Down 8.8% June 20, 2024 | marketbeat.com4,958,143 Shares in BeyondSpring Inc. (NASDAQ:BYSI) Bought by Decheng Capital LLCMay 30, 2024 | marketbeat.comBeyondSpring (NASDAQ:BYSI) shareholders have earned a 141% return over the last yearMay 22, 2024 | finance.yahoo.comBeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED TherapeuticsMay 16, 2024 | globenewswire.comBeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED TherapeuticsMay 3, 2024 | globenewswire.comBeyondSpring GAAP EPS of -$0.54, revenue of $1.75MApril 30, 2024 | msn.comBeyondSpring Provides Business Update and Reports Year End 2023 Financial ResultsApril 29, 2024 | globenewswire.comBeyondSpring Files 2023 Annual Report on Form 20-FApril 29, 2024 | globenewswire.comBeyondSpring Inc. (NASDAQ:BYSI) Sees Significant Increase in Short InterestMarch 30, 2024 | marketbeat.comBeyondSpring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in a Phase 2 Investigator-initiated Study of First-Line Extensive-Stage Small-Cell Lung CancerMarch 25, 2024 | globenewswire.comBYSI Oct 2024 7.500 callMarch 14, 2024 | finance.yahoo.com4,958,143 Shares in BeyondSpring Inc. (NASDAQ:BYSI) Bought by Decheng Capital Management III Cayman LLCMarch 13, 2024 | marketbeat.comBYSI Mar 2024 7.500 callMarch 7, 2024 | finance.yahoo.comU.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.04%March 6, 2024 | msn.comRetail investors invested in BeyondSpring Inc. (NASDAQ:BYSI) up 125% last week, insiders too were rewardedMarch 6, 2024 | finance.yahoo.comBeyondSpring Regains Compliance with Nasdaq Minimum Bid Price and Periodic Filing RequirementsMarch 5, 2024 | finance.yahoo.comBeyondSpring Inc. (BYSI) stock historical prices & data – Yahoo FinanceFebruary 22, 2024 | uk.finance.yahoo.com Get BeyondSpring News Delivered to You Automatically Sign up to receive the latest news and ratings for BYSI and its competitors with MarketBeat's FREE daily newsletter. Email Address BYSI Media Mentions By Week BYSI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BYSI News Sentiment▼1.890.90▲Average Medical News Sentiment BYSI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BYSI Articles This Week▼20▲BYSI Articles Average Week Get BeyondSpring News Delivered to You Automatically Sign up to receive the latest news and ratings for BYSI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MGTX News Today BCAX News Today KURA News Today DNA News Today ATAI News Today ZVRA News Today TYRA News Today MAZE News Today VALN News Today SEPN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BYSI) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BeyondSpring Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BeyondSpring With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
